The San Francisco precision fermentation company will scale up its process for brewing animal-free egg proteins and other high-functioning ingredients.
The Myco-Protein Innovation Call is focused on scaling the use of fungi as a protein source.
“In seeking Series A investors, we were intentional about collaborating with experienced food industry professionals,” says CEO Matt Gibson.
The Tel Aviv-based startup “feeds microorganisms instead of cows,” allowing it to avoid many of the ecological pitfalls of traditional dairy cattle production, it says.
The Asia Sustainable Foods Platform will co-invest $22.2 million alongside Singapore’s national R&D agency into the new Food Tech Innovation Center.
It’ll use the Series A capital to hire talent and build an in-house facility to create larger quantities of its ingredients for food manufacturers.
The Chicago-based company will use the funds to commercialize its seafood analogs made with microbial fermentation.
The New York-based company plans to scale up production of its fermented bio-textile called Mirai.
The category includes cell-cultured meat, plant-based analogs, fermented and fungi-based proteins, functional foods, and other novel ingredients.
The Berkeley, California-based startup uses genetically modified microflora to ferment sugar into proteins found in cow’s milk.
The Berlin-based startup has set itself the target of replacing 10% of Europe’s dairy products with animal-free versions produced using precision fermentation by 2030.
New Carnivore has made seven deals to date, co-investing with leading VCs such as Andreessen Horowitz, Breakthrough Energy Ventures, and DCVC.
“That’s something we will have to work on. When is the last time that a whole new category of food was created?” says co-founder and CEO Tyler Huggins.
After a limited release of its alt-protein sausage patties and ice cream, Nature’s Fynd is preparing for a full-scale commercial launch.
NTU students will learn the science behind cell-cultured, plant-based, and fermented proteins, as well as the market opportunities and regulatory issues they present.
It’s building a “first of its kind” protein factory in the Netherlands with the aim of producing 1 million tonnes of mycoprotein annually by 2032.
The Ginkgo Bioworks spinout will use the proceeds from the BlackRock and Ontario Teachers’-led Series B round for R&D, commercialization, and hiring.
Monde Nissin raised just over $1 billion in its Philippines IPO – and is earmarking much of it for expansion in the US.
The Viennese startup is verifying the quality of its biological products by working with large-scale distributors to earn farmers’ trust.
It will be the Philippines’ biggest-ever IPO – and it’s being driven by demand for alt-protein and instant noodles.
Sponsored
Collaboration & innovation key to developing farmer-focused carbon markets